| abstract |
Compound represented by formula (I) or a pharmaceutically acceptable salt thereof: wherein: the bicyclic ring that is formed by ring A fused with the adjacent ring is 4,5,6,7-tetrahydroindazol-5-yl; R1 represents cyclopropyl; R3 represents aryl or heteroaryl, which may be substituted respectively with a group selected from group Q; group Q is a group consisting of halogen, C1-6 alkyl, halogen-C1-6 alkyl, -OR0, C1-6-alkylene, -S-C1-6 alkyl, aryl, a heterocyclic group and C1-6 alkylene -heterocyclic group, in which the aryl and heterocyclic group in group Q may be substituted with halogen, cyano, C1-6 alkyl, -OR0 or oxo; and R0 represents -H or C1-6 alkyl. |